Search research articles
Contact Us
Filters
Showing results (71-80 of 125) with videos related to
Page
of 13
Sort By:
The American Journal of Pathology
|
May 17, 2008
Stat3 promotes metastatic progression of prostate cancer
Junaid Abdulghani, Lei Gu, Ayush Dagvadorj, et al.
International Journal of Cancer
|
February 19, 2016
Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy
Lan Yu, Mervi Toriseva, Miikka Tuomala, et al.
Endocrinology
|
April 7, 2007
Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway
Ayush Dagvadorj, Sean Collins, Jean-Baptiste Jomain, et al.
Molecular Cancer Therapeutics
|
March 1, 2014
Pharmacologic suppression of JAK1/2 by JAK1/2 inhibitor AZD1480 potently inhibits IL-6-induced experimental prostate cancer metastases formation
Lei Gu, Pooja Talati, Paraskevi Vogiatzi, et al.
International Journal of Cancer
|
August 21, 2018
Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells
Khalid Saeed, Poojitha Ojamies, Teijo Pellinen, et al.
The American Journal of Pathology
|
February 2, 2011
Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer
Paula Vainio, Santosh Gupta, Kirsi Ketola, et al.
International Journal of Cancer
|
May 4, 2023
Prognostic impact of kallikrein-related peptidase transcript levels in prostate cancer
Timo-Pekka K Lehto, Ruusu-Maaria Kovanen, Susanna Lintula, et al.
Cancer Letters
|
September 25, 2025
AI-informed computational pathology classifier predicts outcomes across treatment modalities in muscle-invasive urothelial carcinoma
Kamal Hammouda, Naoto Tokuyama, Germán Corredor, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 5, 2016
Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy
Peter J Boström, Tuomas Mirtti, Bas van Rhijn, et al.
Cancer Research Communications
|
July 24, 2023
Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma
Moon Hee Lee, Jason Theodoropoulos, Jani Huuhtanen, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 125) with videos related to
Sort By:
Page
of 13
The American Journal of Pathology
|
May 17, 2008
Stat3 promotes metastatic progression of prostate cancer
Junaid Abdulghani, Lei Gu, Ayush Dagvadorj, et al.
International Journal of Cancer
|
February 19, 2016
Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy
Lan Yu, Mervi Toriseva, Miikka Tuomala, et al.
Endocrinology
|
April 7, 2007
Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway
Ayush Dagvadorj, Sean Collins, Jean-Baptiste Jomain, et al.
Molecular Cancer Therapeutics
|
March 1, 2014
Pharmacologic suppression of JAK1/2 by JAK1/2 inhibitor AZD1480 potently inhibits IL-6-induced experimental prostate cancer metastases formation
Lei Gu, Pooja Talati, Paraskevi Vogiatzi, et al.
International Journal of Cancer
|
August 21, 2018
Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient-derived cancer cells
Khalid Saeed, Poojitha Ojamies, Teijo Pellinen, et al.
The American Journal of Pathology
|
February 2, 2011
Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer
Paula Vainio, Santosh Gupta, Kirsi Ketola, et al.
International Journal of Cancer
|
May 4, 2023
Prognostic impact of kallikrein-related peptidase transcript levels in prostate cancer
Timo-Pekka K Lehto, Ruusu-Maaria Kovanen, Susanna Lintula, et al.
Cancer Letters
|
September 25, 2025
AI-informed computational pathology classifier predicts outcomes across treatment modalities in muscle-invasive urothelial carcinoma
Kamal Hammouda, Naoto Tokuyama, Germán Corredor, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 5, 2016
Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy
Peter J Boström, Tuomas Mirtti, Bas van Rhijn, et al.
Cancer Research Communications
|
July 24, 2023
Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma
Moon Hee Lee, Jason Theodoropoulos, Jani Huuhtanen, et al.
Page
of 13